The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...